Characteristics and symptomatology of major depressive disorder with atypical features from symptom to syndromal level

被引:0
|
作者
Shi, Yifan [1 ]
Peng, Daihui [2 ]
Zhang, Chen [2 ]
Mellor, David [3 ]
Wang, Huaning [1 ]
Fang, Yiru [2 ,4 ,5 ,6 ]
Wu, Zhiguo [7 ,8 ,9 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Div Mood Disorders, Sch Med, Shanghai, Peoples R China
[3] Deakin Univ, Sch Psychol, Melbourne, Australia
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Psychiat & Affect Disorders Ctr, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[5] Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China
[6] CAS Ctr Excellence Brain Sci & Intelligence Techno, Shanghai, Peoples R China
[7] Shanghai Yangpu Dist Mental Hlth Ctr, Shanghai, Peoples R China
[8] Shanghai Univ Med & Hlth Sci, Clin Res Ctr Mental Hlth, Shanghai, Peoples R China
[9] Shanghai Univ Med & Hlth Sci, Yangpu Dist Mental Hlth Ctr, Clin Res Ctr Mental Hlth, 585 Jungong Rd, Shanghai 200030, Peoples R China
关键词
Major depressive disorder; Atypical depression; Atypical features; Depressive symptoms; RISK-FACTORS; CLINICAL CHARACTERISTICS; SUICIDAL IDEATION; COMORBIDITY; PREVALENCE; SUBTYPES; EPIDEMIOLOGY; VALIDATION; ANXIETY; ZURICH;
D O I
10.1016/j.jad.2023.04.062
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To explore clinical characteristics and symptomatology of major depressive disorder (MDD) with atypical features based on DSM criteria or only reversed vegetative symptoms. Method: A total of 3187 patients who met DSM-IV TR criteria for MDD were enrolled. Demographics and symptomatology covering multiple symptom domains were assessed and compared between three groups of cases: those who met DSM criteria for atypical specifier (the DAD group), those who had at least one reversed vegetative symptoms (hypersomnia or hyperphagia) (the SAD group) without meeting DSM atypical specifier criteria, and those without any reversed vegetative symptoms (the NAD group). Results: The DAD and SAD group accounted for 4.4% and 14.4% of the participants, respectively. The DAD cases were characterized by a highest proportion of hospitalizations, longest duration of current episode and worst quality of life. The DAD and SAD cases were more likely to adopt unhealthy behaviors (smoking and alcohol drinking). Most depressive symptoms related to higher illness severity and treatment resistance were more frequent in the DAD cases, followed by the SAD cases, and least frequent in the NAD cases. Limitations: A cross-sectional design and a non-validated questionnaire were used. Conclusions: The findings support the role of DSM defined atypical depression as a valid MDD subtype and provide evidence for clinical utility of the simplified approach of defining atypical features based on only reversed vegetative symptoms. This has implications for illness screening, public health, suicide prevention and better treatment planning for depressed individuals with atypical features even below syndromal level.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 50 条
  • [21] Disentangling dysthymia from major depressive disorder in suicide attempters' suicidality, comorbidity and symptomatology
    Holmstrand, Cecilia
    Engstroem, Gunnar
    Traeskman-Bendz, Lil
    NORDIC JOURNAL OF PSYCHIATRY, 2008, 62 (01) : 25 - 31
  • [22] The clinical correlates of comorbid anxiety symptoms and syndromal anxiety in patients with major depressive disorder
    Wu Zhiguo
    Lan Cao
    Peng Daihui
    Mellor, David
    Chen, Zhang
    Li Haozhe
    Wang Zuowei
    Song Yanyan
    Li Chunbo
    Fang Yiru
    PSYCHIATRY RESEARCH, 2018, 269 : 251 - 257
  • [23] Perfectionism and depression symptom severity in major depressive disorder
    Enns, MW
    Cox, BJ
    BEHAVIOUR RESEARCH AND THERAPY, 1999, 37 (08) : 783 - 794
  • [24] Wearable technology for symptom measurement in major depressive disorder
    Woo, Benjamin K. P.
    Chung, Jamie O. P.
    Shu, Sara
    Zhu, Pengyi
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 317 : 5 - 5
  • [25] Use of Non-Psychiatric Medications With Potential Depressive Symptom Side Effects and Level of Depressive Symptoms in Major Depressive Disorder
    Mojtabai, Ramin
    Amin-Esmaeili, Masoumeh
    Spivak, Stanislav
    Olfson, Mark
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (04)
  • [26] Biological Mechanisms of Atypical and Melancholic Major Depressive Disorder
    Tarasov, V. Vadim
    Ivanets, N. Nikolay
    Svistunov, A. Andrey
    Chubarev, N. Vladimir
    Kinkulkina, A. Marina
    Tikhonova, G. Yuliya
    Syzrantsev, S. Nikita
    Chubarev, V. Ivan
    Muresanu, Cristian
    Somasundaram, G. Siva
    Kirkland, E. Cecil
    Aliev, Gjumrakch
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (31) : 3399 - 3412
  • [27] Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features
    Trivedi, Madhukar H.
    Thase, Michael E.
    Fava, Maurizio
    Nelson, J. Craig
    Yang, Huyuan
    Qi, Ying
    Tran, Quynh-Van
    Pikalov, Andrei
    Carlson, Berit X.
    Marcus, Ronald N.
    Berman, Robert M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (12) : 1928 - 1936
  • [28] Treating major depressive disorder with mixed features
    Fagiolini, Andrea
    Cuomo, Alessandro
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 69 : 58 - 59
  • [29] A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder
    Lange, Sjors M. M.
    Schirmbeck, Frederike
    Stek, Max L.
    Jansen, Yentl R. Murk
    Rooijen, Geeske van
    Haan, Lieuwe de
    Penninx, Brenda W. J. H.
    Rhebergen, Didi
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 135 : 143 - 151
  • [30] Differential criterion functioning of alcohol use symptomatology in major depressive disorder?
    Lynskey, M. T.
    Agrawal, A.
    PSYCHOLOGICAL MEDICINE, 2008, 38 (03) : 441 - 449